Advertisement
Новости Форекс
Takeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis
Japan's Takeda Pharmaceutical Co. Ltd. (TAK) announced Monday that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and only FDA-approved oral therapy for people 11 years and older with eosinophilic esophagitis (EoE)1 It will be available in 2 mg/10 mL convenient, single-dose stick packs by the end of February.
RTTNews |
552 дней спустя
Bay Street Likely To Open On Subdued Note
Canadian shares are likely to open flat or slightly lower Monday morning, tracking weak crude oil prices. With U.S. inflation data due on Tuesday, the mood is likely to remain cautious and activity is expected to be mostly stock specific.
RTTNews
|
552 дней спустя
India Inflation Softens On Cooling Food Costs
India consumer price inflation softened to a three-month low in January on moderating food price growth, data from the Ministry of Statistics and Programme Implementation showed Monday. The consumer price index posted an annual growth of 5.10 percent, weaker than the 5.69 percent increase in December, which was the fastest in four months.
RTTNews
|
552 дней спустя
Visa Adds Digital Wallet Features To Commercial Pay In Collaboration With Conferma Pay
Digital payments firm Visa, Inc. (V) announced Monday extended digital wallet capabilities within Visa Commercial Pay, a suite of B2B payment solutions built in partnership with Conferma Pay, to revolutionize how businesses manage transactions globally.
RTTNews
|
552 дней спустя
Merck Says Health Canada Oks KEYTRUDA In Combination With Trastuzumab And Chemotherapy
Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, announced Monday that Health Canada has granted approval of KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in combination with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy, for the first-line treatment of adult patients with locally advanced unresectable or metastatic HER2 positive gastric or gastroesophageal junction (GEJ) adenocarcinoma, whose tumors express PD-L1 as determined by a validated test.
RTTNews
|
552 дней спустя
Yen Rises Against Majors
The Japanese yen weakened against other major currencies in the European session on Monday.
RTTNews
|
552 дней спустя
Sensex, Nifty Decline Ahead Of Key Inflation Readings
Indian shares fell notably on Monday as investors stayed on the sidelines ahead of key retail inflation data due this week.
RTTNews
|
552 дней спустя
more news
European Shares Inch Higher Ahead Of Busy Week For Economic Data
European stocks were broadly higher on Monday ahead of a busy week packed with earnings, economic data releases and speeches by Federal Reserve officials.
RTTNews
|
552 дней спустя
FTSE 100 Little Changed Ahead Of Key Inflation, GDP Data
U.K. stocks were subdued on Monday ahead of key U.S. CPI data as well as U.K. GDP and inflation readings due this week.
RTTNews
|
552 дней спустя
CAC 40 Gains As Iran Signals Progress In Talks On Israel-Hamas War
French stocks traded higher on Monday after Iranian Foreign Minister Hossein Amir-Abdollahian said on Saturday that his country did not want to see an expansion of the war in the region.
RTTNews
|
552 дней спустя
DAX Modestly Higher In Cautious Trade
German stocks were seeing modest gains on Monday ahead of a busy week packed with earnings, economic data releases and speeches by Federal Reserve officials.
RTTNews
|
552 дней спустя
Uber Eats Edits Super Bowl Ad After Backlash
Uber Eats has edited its Super Bowl advertisement, removing a portion that joked about dangerous peanut allergies. The food delivery firm had faced severe backlash for making fun of food allergies, which could cause millions of people to struggle for their lives. Super Bowl commercials are featured in the U.S. television broadcast of the Super Bowl...
RTTNews
|
552 дней спустя
NZ Dollar Falls Against Majors
The New Zealand dollar weakened against other major currencies in the Asian session on Monday.
RTTNews
|
553 дней спустя
Stay up to date!
Add Новости to your browser
Add To Chrome
